<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">345823</id>
  <title nil="true"/>
  <common-name>9-bromo-5-methyl-2-naphthalen-2-yl-5-(4-nitrophenyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine</common-name>
  <description>9-bromo-5-methyl-2-naphthalen-2-yl-5-(4-nitrophenyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine is a chemical compound with the formula C27H20BrN3O3. With an average molecular weight of 514.40 g/mol, 9-bromo-5-methyl-2-naphthalen-2-yl-5-(4-nitrophenyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>3308471</pubchem-id>
  <chemical-formula>C27H20BrN3O3</chemical-formula>
  <weight>514.4</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T08:49:54Z</created-at>
  <updated-at type="dateTime">2026-08-31T08:49:54Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CC1(N2C(CC(=N2)C3=CC4=CC=CC=C4C=C3)C5=C(O1)C=CC(=C5)Br)C6=CC=C(C=C6)[N+](=O)[O-]</moldb-smiles>
  <moldb-formula>C27H20BrN3O3</moldb-formula>
  <moldb-inchi>InChI=1S/C27H20BrN3O3/c1-27(20-8-11-22(12-9-20)31(32)33)30-25(23-15-21(28)10-13-26(23)34-27)16-24(29-30)19-7-6-17-4-2-3-5-18(17)14-19/h2-15,25H,16H2,1H3</moldb-inchi>
  <moldb-inchikey>VSORIHJBWAZUSX-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">513.0688</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>6.8</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM341716</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>9-bromo-5-methyl-2-naphthalen-2-yl-5-(4-nitrophenyl)-1,10b-dihydropyrazolo[1,5-c][1,3]benzoxazine</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Benzoxazines</klass>
  <subklass nil="true"/>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0296177</sync-id>
  <structure-inchikey>VSORIHJBWAZUSX-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>2000000000000000000000000000000000000000000180000010000000000000000000000200000000000002000000000000000080000000008000000100000000008000000000200000000000020800000000000001000800100400240000000000000000200000000100000800400020100008000000001000000101110000048000001800000000000000004800000001100000000000000000020200000008000000008000000080000000000008000000200000000000000000000000000000000000000000100008000000000000000000000000200000000000000420000000001000040000000400000100800405000000000000000010000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAiAAAAJwAAAIABBgBgAAAAAQMGACAAAAAE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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:44:45Z</structure-indexed-at>
</compound>
